{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:14:15Z","timestamp":1779894855613,"version":"3.53.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.critrevonc.2021.103437","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T12:02:02Z","timestamp":1627992122000},"page":"103437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin\u2019s Lymphoma"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-1260","authenticated-orcid":false,"given":"Michela","family":"Buglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2094-1062","authenticated-orcid":false,"given":"Andrea Emanuele","family":"Guerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-7869","authenticated-orcid":false,"given":"Andrea Riccardo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Spiazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6708-8148","authenticated-orcid":false,"given":"Nadia","family":"Pasinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Magli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Toraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-7908","authenticated-orcid":false,"given":"Paolo","family":"Borghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Alghisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Giaj Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Pegurri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4126-733X","authenticated-orcid":false,"given":"Stefano Maria","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"June (18)","key":"10.1016\/j.critrevonc.2021.103437_bib0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1200\/JCO.2016.70.9410","article-title":"Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials","volume":"35","author":"Sasse","year":"2017","journal-title":"J Clin Oncol."},{"issue":"March (9)","key":"10.1016\/j.critrevonc.2021.103437_bib0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/JCO.18.01652","article-title":"Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study","volume":"37","author":"Biccler","year":"2019","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/725219","article-title":"Incidence Patterns and Outcomes for Hodgkin Lymphoma Patients in the United States","volume":"2011","author":"Shenoy","year":"2011","journal-title":"Adv Hematol."},{"issue":"May (14)","key":"10.1016\/j.critrevonc.2021.103437_bib0020","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.2010.32.8427","article-title":"Long-term complications of lymphoma and its treatment","volume":"29","author":"Ng","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0025","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","article-title":"Second malignancy after Hodgkin\u2019s Disease treated with radiation therapy with or without chemotherapy: long term risks and risk factors","volume":"100","author":"Ng","year":"2002","journal-title":"Blood"},{"issue":"April (5)","key":"10.1016\/j.critrevonc.2021.103437_bib0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0360-3016(00)01513-3","volume":"49","author":"Cellai","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0035","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","article-title":"Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"March (9)","key":"10.1016\/j.critrevonc.2021.103437_bib0040","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2009.25.3260","article-title":"Treatment of favorable, limited-stage Hodgkin\u2019s lymphoma with chemotherapy without consolidation by radiation therapy","volume":"28","author":"Canellos","year":"2010","journal-title":"J Clin Oncol."},{"issue":"February (5)","key":"10.1016\/j.critrevonc.2021.103437_bib0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1111961","article-title":"ABVD alone versus radiation-based therapy in limited-stage Hodgkin\u2019s lymphoma","volume":"366","author":"Meyer","year":"2012","journal-title":"N Engl J Med."},{"issue":"April (17)","key":"10.1016\/j.critrevonc.2021.103437_bib0050","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma","volume":"372","author":"Radford","year":"2015","journal-title":"N Engl J Med."},{"issue":"June (16)","key":"10.1016\/j.critrevonc.2021.103437_bib0055","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC\/LYSA\/FIL H10 Trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol."},{"issue":"November (31)","key":"10.1016\/j.critrevonc.2021.103437_bib0060","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.19.00964","article-title":"Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group","volume":"37","author":"Fuchs","year":"2019","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103437_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007110.pub2","article-title":"Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma","author":"Herbst","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/485071","article-title":"The Role of Radiotherapy in Hodgkin\u2019s Lymphoma: What Has Been Achieved during the Last 50 Years?","volume":"2015","author":"Witkowska","year":"2015","journal-title":"Biomed Res Int."},{"issue":"July (3)","key":"10.1016\/j.critrevonc.2021.103437_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijrobp.2019.02.001","article-title":"The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"104","author":"Mikhaeel","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood."},{"issue":"August (24)","key":"10.1016\/j.critrevonc.2021.103437_bib0085","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian-Danish study","volume":"25","author":"Gallamini","year":"2007","journal-title":"J Clin Oncol."},{"issue":"August (5)","key":"10.1016\/j.critrevonc.2021.103437_bib0090","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2015.04.021","article-title":"Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy","volume":"92","author":"Simontacchi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"October (19)","key":"10.1016\/j.critrevonc.2021.103437_bib0095","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","volume":"21","author":"Engert","year":"2003","journal-title":"J Clin Oncol."},{"issue":"July (4)","key":"10.1016\/j.critrevonc.2021.103437_bib0100","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"June (3)","key":"10.1016\/j.critrevonc.2021.103437_bib0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines","volume":"79","author":"Girinsky","year":"2006","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2012.08.041","article-title":"Involved node radiation therapy: an effective alternative in early-stage Hodgkin lymphoma","volume":"85","author":"Maraldo","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"June (2)","key":"10.1016\/j.critrevonc.2021.103437_bib0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2014.01.041","article-title":"Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma","volume":"89","author":"Filippi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"March (4)","key":"10.1016\/j.critrevonc.2021.103437_bib0120","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ijrobp.2011.05.015","article-title":"Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin\u2019s lymphoma","volume":"82","author":"Paumier","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/0284186X.2014.932435","article-title":"Prospective Phase II Trial of Image-Guided Radiotherapy in Hodgkin Lymphoma: Benefit of Deep Inspiration Breath-Hold","volume":"54","author":"Petersen","year":"2015","journal-title":"Acta Oncol"},{"issue":"November (6)","key":"10.1016\/j.critrevonc.2021.103437_bib0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.prro.2019.05.009","article-title":"Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma","volume":"9","author":"Everett","year":"2019","journal-title":"Pract Radiat Oncol."},{"issue":"December (5)","key":"10.1016\/j.critrevonc.2021.103437_bib0135","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ijrobp.2014.06.069","article-title":"A decade of comparative dose planning studies for early-stage Hodgkin lymphoma: what can we learn?","volume":"90","author":"Maraldo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103437_bib0140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijrobp.2004.08.048","article-title":"Intensity-modulated radiotherapy for lymphoma involving the mediastinum","volume":"62","author":"Goodman","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103437_bib0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijrobp.2005.06.004","volume":"64","author":"Girinsky","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103437_bib0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.radonc.2006.10.015","article-title":"Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts","volume":"82","author":"Nieder","year":"2007","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103437_bib0155","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ijrobp.2008.12.048","article-title":"Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin\u2019s lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy","volume":"75","author":"Chera","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1748-717X-5-33","article-title":"Radiotherapy of large target volumes in Hodgkin\u2019s lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques","volume":"5","author":"Cella","year":"2010","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103437_bib0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2011.12.034","article-title":"Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma","volume":"84","author":"Hoppe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0170","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/annonc\/mdr439","article-title":"Minimising critical organ irradiation in limited stage Hodgkin lymphoma: A dosimetric study of the benefit of involved node radiotherapy","volume":"23","author":"Campbell","year":"2012","journal-title":"Ann Oncol"},{"issue":"August","key":"10.1016\/j.critrevonc.2021.103437_bib0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1748-717X-7-129","article-title":"Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?","volume":"7","author":"De Sanctis","year":"2012","journal-title":"Radiat Oncol."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1748-717X-8-112","article-title":"Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease","volume":"8","author":"Antoni","year":"2013","journal-title":"Radiat Oncol."},{"issue":"August (8)","key":"10.1016\/j.critrevonc.2021.103437_bib0185","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"24","author":"Maraldo","year":"2013","journal-title":"Ann Oncol."},{"issue":"Winter (4)","key":"10.1016\/j.critrevonc.2021.103437_bib0190","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.meddos.2013.04.004","article-title":"Use of volumetric-modulated arc therapy for treatment of Hodgkin lymphoma","volume":"38","author":"Lee","year":"2013","journal-title":"Med Dosim."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1748-717X-9-94","article-title":"Dosimetric advantages of a \"butterfly\" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin\u2019s lymphoma","volume":"9","author":"Voong","year":"2014","journal-title":"Radiat Oncol"},{"issue":"May (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2015.02.030","article-title":"Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk","volume":"92","author":"Filippi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"May (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","article-title":"Minimizing Late Effects for Patients With Mediastinal Hodgkin Lymphoma: Deep Inspiration Breath-Hold, IMRT, or Both?","volume":"92","author":"Aznar","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1059","key":"10.1016\/j.critrevonc.2021.103437_bib0210","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150409","article-title":"Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature","volume":"89","author":"Besson","year":"2016","journal-title":"Br J Radiol"},{"issue":"April (2)","key":"10.1016\/j.critrevonc.2021.103437_bib0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canrad.2015.11.002","article-title":"Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin\u2019s lymphoma female patients receiving involved-field or involved site radiation therapy","volume":"20","author":"Horn","year":"2016","journal-title":"Cancer Radiother."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103437_bib0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jnci.2016.04.007","article-title":"Volumetric-modulated arc therapy (VMAT) versus 3D-conformal radiation therapy in supra-diaphragmatic Hodgkin\u2019s Lymphoma with mediastinal involvement: a dosimetric comparison","volume":"28","author":"Higby","year":"2016","journal-title":"J Egypt Natl Canc Inst"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/0284186X.2018.1512153","article-title":"Comparative treatment planning study for mediastinal Hodgkin\u2019s lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy","volume":"58","author":"Edvardsson","year":"2019","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0230","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1748-717X-7-186","article-title":"Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin\u2019s Lymphoma: dosimetric comparison and clinical considerations","volume":"7","author":"Fiandra","year":"2012","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.critrevonc.2021.103437_bib0235","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1120\/jacmp.v13i6.3769","article-title":"Noncoplanar intensity-modulated radiation therapy for young female patients with mediastinal lymphoma","volume":"13","author":"Chen","year":"2012","journal-title":"J Appl Clin Med Phys"},{"issue":"22","key":"10.1016\/j.critrevonc.2021.103437_bib0240","article-title":"Hodgkin\u2019s lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms","volume":"8","author":"Cella","year":"2013","journal-title":"Radiat Oncol"},{"issue":"Spring (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.meddos.2017.08.010","article-title":"A study of the dosimetric characteristics between different fixed-field IMRT and VMAT in early-stage primary mediastinal B-cell lymphoma","volume":"43","author":"Xu","year":"2018","journal-title":"Med Dosim."},{"issue":"December (3)","key":"10.1016\/j.critrevonc.2021.103437_bib0250","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2018.08.017","article-title":"Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma","volume":"129","author":"Starke","year":"2018","journal-title":"Radiother Oncol."},{"issue":"September","key":"10.1016\/j.critrevonc.2021.103437_bib0255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2019.05.009","article-title":"Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin\u2019s lymphoma patients","volume":"138","author":"Levis","year":"2019","journal-title":"Radiother Oncol."},{"issue":"December (5)","key":"10.1016\/j.critrevonc.2021.103437_bib0260","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ijrobp.2009.05.012","article-title":"Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study","volume":"75","author":"Weber","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"October (2)","key":"10.1016\/j.critrevonc.2021.103437_bib0265","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2010.05.035","article-title":"Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients","volume":"81","author":"Weber","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103437_bib0270","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijrobp.2011.05.054","article-title":"Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy","volume":"83","author":"Koeck","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"September (9)","key":"10.1016\/j.critrevonc.2021.103437_bib0275","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00066-015-0839-x","article-title":"Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin\u2019s lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT","volume":"191","author":"Kriz","year":"2015","journal-title":"Strahlenther Onkol."},{"issue":"October (7)","key":"10.1016\/j.critrevonc.2021.103437_bib0280","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3109\/0284186X.2013.813636","article-title":"The effect on esophagus after different radiotherapy techniques for early stage Hodgkin\u2019s lymphoma","volume":"52","author":"J\u00f8rgensen","year":"2013","journal-title":"Acta Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2021.103437_bib0285","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","article-title":"Long-term survival and competing causes of death in patients with early-stage Hodgkin\u2019s disease treated at age 50 or younger","volume":"20","author":"Ng","year":"2002","journal-title":"J Clin Oncol."},{"issue":"September (18)","key":"10.1016\/j.critrevonc.2021.103437_bib0290","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0295","doi-asserted-by":"crossref","DOI":"10.3390\/hemato2030031","article-title":"Advanced Radiotherapy Techniques for Mediastinal Lymphomas: Results from an Italian Survey","author":"Di Russo","year":"2021","journal-title":"Hemato"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0300","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0305","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin\u2019s Disease treated during adolescence or young adulthood","volume":"18","author":"Van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"issue":"December (26)","key":"10.1016\/j.critrevonc.2021.103437_bib0310","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second Cancer Risk Up to 40 Years after Treatment for Hodgkin\u2019s Lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med."},{"issue":"23","key":"10.1016\/j.critrevonc.2021.103437_bib0315","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","article-title":"High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin\u2019s disease: report from the Late Effects Study Group","volume":"21","author":"Bhatia","year":"2003","journal-title":"J Clin Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103437_bib0320","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","article-title":"Lung cancer following chemotherapy and radiotherapy for Hodgkin\u2019s disease","volume":"94","author":"Travis","year":"2002","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"10.1016\/j.critrevonc.2021.103437_bib0325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1667\/0033-7587(2003)159[0161:LCATFH]2.0.CO;2","article-title":"Lung cancer after treatment for Hodgkin\u2019s disease: focus on radiation effects","volume":"159","author":"Gilbert","year":"2003","journal-title":"Radiat Res."},{"issue":"21","key":"10.1016\/j.critrevonc.2021.103437_bib0330","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J Clin Oncol."},{"issue":"March (Suppl. 3)","key":"10.1016\/j.critrevonc.2021.103437_bib0335","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"June (3)","key":"10.1016\/j.critrevonc.2021.103437_bib0340","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.seminoncol.2019.07.006","article-title":"Normal tissue complication probability (NTCP) models for modern radiation therapy","volume":"46","author":"Palma","year":"2019","journal-title":"Semin Oncol."},{"issue":"June (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0345","doi-asserted-by":"crossref","first-page":"10559","DOI":"10.1038\/s41598-020-67499-0","article-title":"The dose-response characteristics of four NTCP models: using a novel CT-based radiomic method to quantify radiation-induced lung density changes","volume":"10","author":"Begosh-Mayne","year":"2020","journal-title":"Sci Rep."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0350","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.prro.2012.12.006","article-title":"Changes in breast cancer risk associated with different volumes, doses and techniques in female Hodgkin\u2019s lymphoma patients treated with supra-diaphragmatic radiotherapy","volume":"3","author":"Filippi","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2017.03.011","article-title":"Risk of second cancers: bridging epidemiology and modeling","author":"Schneider","year":"2017","journal-title":"Phys Med."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0360","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2012.09.001","article-title":"Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies on the radiation dose-response relationship","volume":"86","author":"Berrington de Gonzalez","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0365","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.2012.09211.x","article-title":"Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults","volume":"158","author":"Omer","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0370","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0375","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijrobp.2017.09.039","article-title":"Intensity Modulated Radiation therapy and second cancer risk in adults","volume":"100","author":"Filippi","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103437_bib0380","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.2005.06.225","article-title":"Malignant breast tumors after radiotherapy for a first cancer during childhood","volume":"23","author":"Guibout","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1667\/RR0527.1","article-title":"Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects","volume":"167","author":"Suit","year":"2007","journal-title":"Radiat Res"},{"issue":"June (3)","key":"10.1016\/j.critrevonc.2021.103437_bib0390","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-8140(01)00337-1","article-title":"Breast cancer occurred after treatment for Hodgkin\u2019s disease: analysis of 133 cases","volume":"59","author":"Cutuli","year":"2001","journal-title":"Radiother Oncol."},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2021.103437_bib0395","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s11547-016-0667-9","article-title":"Mammography and MRI for screening women who underwent chest radiation therapy (lymphoma survivors): recommendations for surveillance from the Italian College of Breast Radiologists by SIRM","volume":"121","author":"Mariscotti","year":"2016","journal-title":"Radiol Med."},{"issue":"March (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0400","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13014-020-01504-8","article-title":"Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin\u2019s lymphoma involving the mediastinum","volume":"15","author":"Filippi","year":"2020","journal-title":"Radiat Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103437_bib0405","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2015.02.010","article-title":"Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non-Hodgkin Lymphoma","volume":"92","author":"Pinnix","year":"2015","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103437_bib0410","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.radonc.2015.07.051","article-title":"Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung","volume":"117","author":"Cella","year":"2015","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.critrevonc.2021.103437_bib0415","first-page":"3227","article-title":"Abnormalities of the thyroid in survivors of Hodgkin\u2019s disease: data from the Childhood Cancer Survivor Study","volume":"85","author":"Sklar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103437_bib0420","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.ijrobp.2010.09.054","article-title":"Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin\u2019s lymphoma","volume":"82","author":"Cella","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103437_bib0425","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2018.03.003","article-title":"Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy","volume":"101","author":"Pinnix","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0430","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1667\/RR2240.1","article-title":"Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study","volume":"174","author":"Bhatti","year":"2010","journal-title":"Radiat Res"},{"issue":"July (4)","key":"10.1016\/j.critrevonc.2021.103437_bib0435","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cllc.2011.03.026","article-title":"Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database","volume":"12","author":"Werner-Wasik","year":"2011","journal-title":"Clin Lung Cancer."},{"issue":"March (Suppl. 3)","key":"10.1016\/j.critrevonc.2021.103437_bib0440","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","article-title":"Radiation dose-volume effects in the spinal cord","volume":"76","author":"Kirkpatrick","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0445","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0450","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","article-title":"Role of cancer treatment in long term overall and cardiovascular mortality after childhood cancer","volume":"28","author":"Tukenova","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.critrevonc.2021.103437_bib0455","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2021.103437_bib0460","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2021.103437_bib0465","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2014.01.021","article-title":"Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis","volume":"89","author":"Girinsky","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103437_bib0470","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","article-title":"Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study","volume":"99","author":"Swerdlow","year":"2007","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103437_bib0475","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol."},{"issue":"16","key":"10.1016\/j.critrevonc.2021.103437_bib0480","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"van Nimwegen","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2021.103437_bib0485","doi-asserted-by":"crossref","first-page":"djv008","DOI":"10.1093\/jnci\/djv008","article-title":"Risk of valvular heart disease after treatment for Hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0490","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.radonc.2017.01.008","article-title":"A cardiac atlas for contouring","volume":"122","author":"Duane","year":"2017","journal-title":"Radiother Oncol"},{"issue":"October (2)","key":"10.1016\/j.critrevonc.2021.103437_bib0495","article-title":"The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era","author":"Hoppe","year":"2019","journal-title":"Pract Radiat Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2021.103437_bib0500","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.ijrobp.2018.06.230","article-title":"A Prospective, Observational Study Evaluating Early Subclinical Cardiotoxicity With Global Longitudinal Strain Imaging In Lymphoma Patients Treated With Chemotherapy +\/- Mediastinal Radiotherapy: The CARDIOCARE Project","volume":"102","author":"Levis","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2021.103437_bib0505","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ijrobp.2017.03.026","article-title":"Late cardiac toxicity after mediastinal radiation therapy for Hodgkin lymphoma: contributions of coronary artery and whole heart dose-volume variables to risk prediction","volume":"98","author":"Hahn","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.critrevonc.2021.103437_bib0510","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1080\/10428190802140873","article-title":"Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy","volume":"49","author":"Myrehaug","year":"2008","journal-title":"Leuk Lymphoma."},{"issue":"December (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0515","first-page":"323","volume":"2016","author":"van Leeuwen","year":"2016","journal-title":"Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. Hematology Am Soc Hematol Educ Program."},{"key":"10.1016\/j.critrevonc.2021.103437_bib0520","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1002\/cncr.26186","article-title":"Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis","volume":"117","author":"Vogelius","year":"2011","journal-title":"Cancer"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2021.103437_bib0525","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijrobp.2017.09.036","article-title":"Deep-Inspiration Breath-Hold Intensity Modulated Radiation Therapy to the Mediastinum for Lymphoma Patients: Setup Uncertainties and Margins","volume":"100","author":"Aristophanous","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"October (16)","key":"10.1016\/j.critrevonc.2021.103437_bib0530","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood."},{"issue":"October","key":"10.1016\/j.critrevonc.2021.103437_bib0535","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.2147\/OTT.S220730","article-title":"Proton Therapy For Lymphomas: Current State Of The Art","volume":"12","author":"Ricardi","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2021.103437_bib0540","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11912-017-0592-7","article-title":"Optimal Therapy for Early-Stage Hodgkin\u2019s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy","volume":"19","author":"Filippi","year":"2017","journal-title":"Curr Oncol Rep."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821002250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821002250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:39:19Z","timestamp":1760902759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842821002250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":108,"alternative-id":["S1040842821002250"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103437","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin\u2019s Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103437"}}